Jubilant Biosys, a subsidiary of Jubilant Organosys, has developed a next generation screening solution, a software branded as Legend NGSS, to acceperate drug discovery programme.
The software, to be launched in the US and Europe initially, will allow scientists to capture, store, and analyze Oracle 9i/10g based screening data with greater flexibility, accuracy and speed, a company release said.
Legend NGSS allows users to create rich visualization and interactive analysis reports, including dose-response curves and scatter plot heat maps.
The novel tool allows flexible and interactive mother to daughter plate mapping from any plate reader. This generates best-fit kinetic and time course assays, without internal IT intervention, complete management of compound and targeted libraries, and optimized on-the fly curve-fitting techniques.
